Modulo Bio

Seed
modulo.bio Biotech & Healthcare
Total Funding $12.8M
Latest Round $4.8M Seed
Last Announced Mar 19, 2025
Investors Undisclosed
Decision Makers 6 Verified

About Modulo Bio

Modulo is decoding the neuroimmune system. Applying science and engineering to identify new treatment paths for neurodegenerative diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website modulo.bio
Domain Registered Date Oct 13, 2021

Social & Network Presence

X / Twitter Profile @ModuloBio (67 followers) Created on May 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Raised $4,800,000 · Venture Round

    fundraisingfox.com

  2. Capital Raise

    Seed announced

    fundraisingfox.com

  3. Capital Raise

    Raised $8,000,000 · Venture Round

    fundraisingfox.com

  4. Milestone

    Website domain registered

    modulo.bio

  5. Milestone

    X account created (@ModuloBio)

    67 followers

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Modulo Bio.

Funding History

3 Rounds
Venture Round · Mar 19, 2025
Seed · Dec 5, 2024
Venture Round · Jun 2, 2023

Founders & Leadership

3

Justin Ichida

Co-founder

Work email & phone locked Unlock →

Mike Horowitz

CEO & Co-founder

Work email & phone locked Unlock →

Scott Patterson

CTO & Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts